Drug Approval | April 21, 2025
FDA approves Medtronic’s new Simplera Sync sensor for the MiniMed 780G system
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
Rising demands and advancements in eye care drive growth
According to IQVIATM sales data for the 12-month period ending February 2025, the Adderall Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market3 achieved annual sales of approximately $421.7 million.
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Women Health Card was launched exclusively for women health workers of the Tiruchirappalli City Corporation
More than 40 types of Amyloid proteins are discovered till date
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
Subscribe To Our Newsletter & Stay Updated
